dr. nowakowski on next steps with emerging agents in mcl
Published 7 years ago • 233 plays • Length 2:14Download video MP4
Download video MP3
Similar videos
-
1:19
dr. nowakowski on the potential role of immunotherapy in mcl
-
0:58
dr. nowakowski on biological heterogeneity in newly diagnosed patients with mcl
-
0:50
dr. nowakowski on evolving treatment paradigm of mcl
-
1:00
dr. nowakowski on using patient performance score and age for mcl treatment
-
0:59
dr. nowakowski on the rationale of the engine trial in dlbcl
-
1:25
dr. nowakowski on the rationale for reevaluating enzastaurin in dlbcl
-
0:43
dr. wang discusses next steps with acalabrutinib in mcl
-
1:14:44
taking the leap with innovative strategies in mcl
-
21:05
immunomodulation of nk cells for the treatment of lymphoid malignancies
-
6:00
mantle cell lymphoma: improved prognosis
-
1:57
dr. wang on combatting car t-cell therapy resistance in mcl
-
1:01
dr. wang on future research with car t-cell therapy in mcl
-
1:08
dr. gerson on updates in relapsed/refractory mcl
-
1:27
dr. rule on the combination of venetoclax and ibrutinib in mcl
-
1:32
dr. zelenetz on zanubrutinib research in mcl
-
1:23
dr. rule on the future treatment paradigm in mcl
-
1:29
dr. shah on emerging developments in mcl
-
1:13
dr. ansell on recent therapeutic advancements in mcl
-
1:58
dr. wang on car t-cell therapy resistance in mcl
-
0:57
dr. visco on the utility of bendamustine in mcl
-
0:56
dr. kahl on the potential of car t-cell therapy in mcl
-
0:58
dr. kolibaba on mechanism of action with entospletinib in mcl